Risk factors for silent new ischemic cerebral lesions following carotid artery stenting.
Xiaoyu XuYao FengXuesong BaiYan MaYabing WangYanfei ChenBin YangFeng LingXiaoman ZhangLingyun JiaPublished in: Neuroradiology (2020)
Patients with diabetes, calcified or ulcerated plaques who undergo CAS with open-cell stent application, are at high risk of sNICL. Large-scale prospective randomized controlled trials are needed to confirm these findings.
Keyphrases
- randomized controlled trial
- crispr cas
- single cell
- cerebral ischemia
- minimally invasive
- subarachnoid hemorrhage
- genome editing
- cell therapy
- antiplatelet therapy
- ischemia reperfusion injury
- stem cells
- brain injury
- acute coronary syndrome
- atrial fibrillation
- mesenchymal stem cells
- blood brain barrier
- meta analyses
- bone marrow